14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $36.77 $55.69 Wednesday, 1st May 2024 BHVN stock ended at $40.18. This is 3.56% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 8.34% from a day low at $38.43 to a day high of $41.64.
90 days $36.77 $62.21
52 weeks $13.03 $62.21

Historical Biohaven Pharmaceutical Holding Company Ltd prices

Date Open High Low Close Volume
Jul 17, 2023 $24.22 $26.64 $24.12 $26.41 1 314 913
Jul 14, 2023 $24.26 $24.48 $23.93 $24.07 432 197
Jul 13, 2023 $25.22 $25.31 $24.26 $24.50 457 726
Jul 12, 2023 $24.87 $25.13 $23.74 $25.00 882 126
Jul 11, 2023 $23.25 $24.62 $23.00 $24.60 961 756
Jul 10, 2023 $22.65 $23.40 $22.65 $23.22 473 432
Jul 07, 2023 $22.91 $23.53 $22.62 $22.74 562 793
Jul 06, 2023 $22.75 $23.02 $22.48 $22.91 562 466
Jul 05, 2023 $23.12 $23.53 $22.54 $23.14 714 657
Jul 03, 2023 $23.92 $24.39 $23.02 $23.41 289 225
Jun 30, 2023 $24.46 $24.94 $23.89 $23.92 1 038 157
Jun 29, 2023 $24.56 $24.69 $23.58 $23.93 564 780
Jun 28, 2023 $23.12 $24.94 $22.82 $24.50 1 211 963
Jun 27, 2023 $22.65 $23.42 $22.01 $23.22 662 722
Jun 26, 2023 $23.10 $23.47 $22.34 $22.60 630 158
Jun 23, 2023 $23.46 $23.58 $22.58 $23.20 590 705
Jun 22, 2023 $22.66 $24.11 $22.65 $23.88 739 170
Jun 21, 2023 $23.82 $24.34 $22.60 $22.94 754 446
Jun 20, 2023 $23.60 $24.10 $23.16 $23.82 676 034
Jun 16, 2023 $24.73 $24.71 $23.57 $23.65 1 102 251
Jun 15, 2023 $24.11 $24.54 $23.78 $24.44 671 003
Jun 14, 2023 $24.25 $24.25 $24.25 $24.25 0
Jun 13, 2023 $24.07 $24.88 $23.28 $24.25 952 641
Jun 12, 2023 $23.83 $25.11 $23.31 $23.96 1 427 598
Jun 09, 2023 $23.36 $24.30 $23.15 $23.85 988 943
Click to get the best stock tips daily for free!

About Biohaven Pharmaceutical Holding Company Ltd

Biohaven Pharmaceutical Holding Company Ltd Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as re... BHVN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT